Cooper Companies (COO) reported $4.1B in revenue for fiscal 2025, +5.1% year on year. That ranks #915 by revenue among 2853 SEC filers and #80 in Healthcare. Net income was $375M, a net margin of 9.2%. Revenue has grown 8.5% a year on average since 2016 ($2.0B then). The fiscal 2025 balance sheet shows $12.4B in total assets, $125M in cash and $1.9B in long-term debt.

Key figures

$2.0B2016$2.1B2017$2.5B2018$2.7B2019$2.4B2020$2.9B2021$3.3B2022$3.6B2023$3.9B2024$4.1B2025
Cooper Companies — Key figures
Key figuresFY2025YoYSource
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$4.1B+5.1%FY20252025-10-31
Gross profitGrossProfit$2.7B+3.3%FY20252025-10-31
Operating incomeOperatingIncomeLoss$683M−3.2%FY20252025-10-31
Net incomeNetIncomeLoss$375M−4.4%FY20252025-10-31
Operating cash flowNetCashProvidedByUsedInOperatingActivities$796M+12.2%FY20252025-10-31
Capital expenditurePaymentsToAcquirePropertyPlantAndEquipment$362M−14.0%FY20252025-10-31
Total assetsAssets$12.4B+1.7%FY20252026-01-31
Shareholders' equityStockholdersEquity$8.4B+2.9%FY20252026-01-31
CashCashAndCashEquivalentsAtCarryingValue$125M+23.8%FY20252026-01-31
Long-term debtLongTermDebtNoncurrent$1.9B−24.6%FY20252026-01-31

Revenue is total net sales for the fiscal year, taken from each company's own annual filing.

Reported since the last full year

Three-month figures this company has filed since FY2025. A quarter is not comparable with a full year, and these figures are used nowhere else on the site: not in any ranking, not in comparisons, not in the download.

Cooper Companies — Reported since the last full year
QuarterRevenueNet incomeSource
Q1 20262026-04-30$1.1B−$77.9MOpen →
Q2 20262026-07-31$1.1B$433MOpen →

Only periods that end on a calendar quarter appear here. A company whose fiscal year ends in June files on a different calendar, so it has no row.

Where this sits in its sector

Each bar is the spread of the whole sector: the box covers the middle half of companies, the line inside it the median, and the triangle this company. The axis is clipped at the 5th and 95th percentile so a single outlier does not flatten it.

Cooper Companies — Where this sits in its sector
Where this sits in its sectorFY2025Position in sector
Net marginRank 58 of 161 companies compared9.2%
Operating marginRank 49 of 160 companies compared16.7%
R&D as share of revenueRank 79 of 102 companies compared4.2%
Cash as share of revenueRank 140 of 160 companies compared3.1%

All four are ratios derived from two reported lines, not single filing items. Peer group: companies in the same sector with revenue of $1bn or more; loss-making companies are included.

Profile

Legal name
Cooper Companies, Inc.
Ticker
COO
Exchange
Nasdaq
SIC classification
Ophthalmic Goods (3851)
Fiscal year end
10-31
CIK
0000711404

Filings

Similar in size, same sector

CompanyRevenueNet income
Idexx LaboratoriesIDXX$4.3B$1.1B
Jazz PharmaceuticalsJAZZ$4.3B−$356M
PerrigoPRGO$4.3B−$1.4B
Cooper CompaniesCOO$4.1B$375M
Align TechnologyALGN$4.0B$410M
Charles River Laboratories InternationalCRL$4.0B−$144M
Alignment HealthcareALHC$3.9B−$724,000

See the full ranking →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Cooper Companies — Key figures |url=https://companiesranked.com/en/company/cooper-companies |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Cooper Companies — Key figures. CompaniesRanked. https://companiesranked.com/en/company/cooper-companies

BibTeX

@misc{companiesranked-en-company-cooper-companies-2026,
  author       = {{CompaniesRanked}},
  title        = {{Cooper Companies — Key figures}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/cooper-companies}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.